ERBB2 and breast cancer: We verified that expression differences observed across racial category were not confounded by molecular subtype prevalence in the different racial groups, as it is well established that minorities, such as Black women present more often with triple negative breast cancer and Asian and Latinas with HER2 enriched breast cancers than White women8,28,29.